2型糖尿病におけるMASLDと独立して関連しているアテロゲン結合指数:横断的な研究

Jie Sheng^1,2, Shuwei Shi^1,2, Xuan Ma^1,2

¹School of Clinical Medicine, Shandong Second Medical University, Weifang, Shandong, 261000, People's Republic of China.

Diabetes, metabolic syndrome and obesity : targets and therapy

|September 2, 2025

まとめ

代謝機能障害に関連するステアトス性肝疾患 (MASLD) の患者では,アテロゲン結合指数 (ACI) が有意に高くなります. この新しい脂質マーカーは2型糖尿病患者のMASLDと独立して関連しています.

科学分野:

心臓病科
ヘパトロジー
内分泌学

背景:

メタボリック機能障害に関連した脂肪酸性肝疾患 (MASLD) は,肥満や糖尿病などの代謝障害とともに頻繁に発生します.
MASLDに関連して伝統的な脂質パラメータが研究されていますが,新しいマーカーは調査が必要です.
アテロゲン結合指数 (ACI) は新しい脂質マーカーであり,MASLDとの関連は明らかにされていない.

研究の目的:

アテロゲン結合指数 (ACI) とMASLDとの関係を調査する.
2型糖尿病 (T2D) の患者において,ACIがMASLDのマーカーとして機能するかどうかを判断する.

主な方法:

T2D患者2703人を対象とした横断的な研究.
MASLDは超音波で診断された.
ACIはトリグリセリド,非HDLコレステロール,およびHDLコレステロール値を用いて計算された.

主要な成果:

ACIは,MASLD患者と,MASLD患者と比べて有意に高かった (P < 0. 001).
ACIとMASLD (P < 0. 001) の間には正の相関が認められた.
高いACI四分位は独立してMASLDのリスク増加と関連しており,最も高い四分位は3. 6倍のリスク増加を示した (OR: 3. 636, 95%CI: 2. 361- 5. 601).

結論:

ACIはT2D患者のMASLDと独立して相関しています.
ACIは,この集団におけるMASLDのスクリーニングと管理のための貴重なツールとして潜在性を示しています.
MASLDのT2D患者の臨床実務におけるACIの有用性をさらに調査することができます.

キーワード:

アテロゲニク・コンビインド・インデックス代謝機能障害に関連した脂肪性肝疾患 2型糖尿病

さらに関連する動画

07:03

Author Spotlight: Establishing MASLD Cell Models for Investigating Disease Mechanisms and the Lipid-Lowering Effects of Koumiss

Published on: July 19, 2024

1.0K

06:04

Author Spotlight: Assessing the Cardiovascular Profile of Patients with Metabolic Syndrome

Published on: September 27, 2024

1.1K

関連する概念動画

01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...

01:22

Diabetes Mellitus: Type 2 and Gestational

2.9K

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...

2.9K

01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...

01:22

Diabetes Mellitus: Overview and Type I Subtype

3.2K

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...

3.2K

01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...

01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...

関連する実験動画